Latest News about REGN
Recent news which mentions REGN
Earnings Scheduled For November 3, 2022
November 03, 2022
From Benzinga
Here's How Much $1000 Invested In Regeneron Pharmaceuticals 15 Years Ago Would Be Worth Today
November 02, 2022
Tickers
REGN
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
November 01, 2022
From Benzinga
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For October 26, 2022
October 26, 2022
From Benzinga
From Motley Fool
2 Biotech Stocks You Can Buy and Hold for the Next Decade
October 18, 2022
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2022
October 17, 2022
From Benzinga
13 Analysts Have This to Say About Regeneron Pharmaceuticals
October 17, 2022
Tickers
REGN
From Benzinga
3 Red-Hot Stocks That Could Continue to Beat the Market
October 13, 2022
From Motley Fool
From Benzinga
Moderna, Eli Lilly And This Biotechnology Stock Insiders Are Selling
October 10, 2022
From Benzinga
These 7 Biotech Stocks Are Set to Boom in 2023
October 10, 2022
From InvestorPlace
2 Top Healthcare Stocks to Buy Right Now
October 08, 2022
From Motley Fool
Eaton, Wynn Resorts, Lamar Advertising And This Pharma Company Are CNBC's Final Trades
October 06, 2022
From Benzinga
Apple Short Sellers Made $2B In Profits In September, And Shorts In This Biotech Stock Lost $307M
October 05, 2022
From Benzinga
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
October 04, 2022
From Motley Fool
13 Analysts Have This to Say About Regeneron Pharmaceuticals
October 03, 2022
Tickers
REGN
From Benzinga
What 13 Analyst Ratings Have To Say About Regeneron Pharmaceuticals
October 03, 2022
Tickers
REGN
From Benzinga
Hopeful Golden Cross Forms On Regeneron Pharmaceuticals's Chart
October 03, 2022
Tickers
REGN
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
September 29, 2022
From Benzinga
Regeneron-Sanofi's Flagship Dupixent Becomes First FDA-Approved Treatment For Prurigo Nodularis
September 29, 2022
From Benzinga
Ocular Therapeutix's Wet AMD Candidate Shows Sustained, Comparable Clinical Activity Vs. Eylea
September 27, 2022
From Benzinga
The 7 Best Stocks to Buy to Tap Into a Hidden Bull Market
September 27, 2022
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
More ways to get to us
Facebook
Twitter
YouTubeContact the Lethbridge Herald
504 - 7th Street South
Lethbridge, AB T1J 3Z7
[P] (403) 328-4411
[F] (403)328-4536
Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.